{{Rsnum
|rsid=7771466
|Gene=IL17F
|Chromosome=6
|position=52239311
|Orientation=plus
|GMAF=0.07943
|Gene_s=IL17F
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 9.7 | 90.3
| HCB | 2.9 | 24.8 | 72.3
| JPT | 2.7 | 19.5 | 77.9
| YRI | 0.0 | 14.3 | 85.7
| ASW | 0.0 | 14.0 | 86.0
| CHB | 2.9 | 24.8 | 72.3
| CHD | 2.8 | 22.9 | 74.3
| GIH | 1.0 | 13.9 | 85.1
| LWK | 0.0 | 5.5 | 94.5
| MEX | 0.0 | 17.2 | 82.8
| MKK | 0.0 | 9.0 | 91.0
| TSI | 0.0 | 9.8 | 90.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=22142827
|Title=A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}